Titan Medical to Present and Exhibit at the Society of Robotic Surgery 2019 Annual Meeting
13 Junho 2019 - 9:25AM
Business Wire
Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD)
(Nasdaq: TMDI), a medical device company focused on the design,
development and commercialization of a robotic surgical system for
application in minimally invasive surgery (“MIS”), announces that
David McNally, President and CEO of Titan Medical, will present in
the plenary session titled “Innovations in Robotic Technologies,
What The Future Holds In Store” on Thursday, June 20 at the Society
of Robotic Surgery 2019 Annual Meeting in Orlando. This
industry-focused plenary session will feature executives from
companies recognized for current and promising technology platforms
in robotic surgery.
Additionally, Mr. McNally will be participating among faculty in
the “Investing in Robotic Surgical Innovation” plenary session on
Saturday, June 22. This unique session will bring together
healthcare experts along with industry leaders and members of the
investment community to discuss the current landscape, future
innovations, and to evaluate the impact and value of robotic
surgery. Titan’s Vice President of Marketing, Sachin Sankholkar
will participate in the panel session addressing “Challenges of
Building New Robots, Understanding the Technological Challenges” on
Friday, June 21. Titan Medical will be present and showcase its new
technology video at its booth in the Exhibit Hall throughout the
meeting.
Mr. McNally, said, “We are pleased to exhibit and honored to
participate as industry faculty at the Society of Robotic Surgery
2019 Annual Meeting, where we will be among clinical and industry
experts in the field of robotic surgery. The SRS Annual Meeting
continues to be an exceptional venue for Titan to present and be
recognized among robotic surgery innovators. We look forward to
sharing our vision and commitment to advancing robotic surgery
during our participation at this year’s meeting.”
The Society of Robotic Surgery 2019 Annual Meeting is
designed to be the most comprehensive robotic surgery symposium,
featuring internationally renowned faculty who are dedicated
experts in their fields of study.
About Titan Medical Inc.
Titan Medical Inc. is focused on computer-assisted robotic
surgical technologies for application in MIS. The Company is
developing a single-port robotic surgical system comprised of a
surgeon-controlled patient cart that includes a 3D high-definition
vision system and multi-articulating instruments for performing MIS
procedures, and a surgeon workstation that provides an advanced
ergonomic interface to the patient cart and a 3D endoscopic view
inside the patient’s body. Titan intends to initially pursue
gynecologic surgical indications for use of its single-port robotic
surgical system.
For more information, please visit the Company’s website at
www.titanmedicalinc.com.
Forward-Looking Statements
This news release contains “forward-looking statements” which
reflect the current expectations of management of the Company’s
future growth, results of operations, performance and business
prospects and opportunities. Wherever possible, words such as
“may”, “would”, “could”, “will”, “anticipate”, “believe”, “plan”,
“expect”, “intend”, “estimate”, “potential for” and similar
expressions have been used to identify these forward-looking
statements. These statements reflect management’s current beliefs
with respect to future events and are based on information
currently available to management. Forward-looking statements
involve significant risks, uncertainties and assumptions. Many
factors could cause the Company’s actual results, performance or
achievements to be materially different from any future results,
performance or achievements that may be expressed or implied by
such forward-looking statements, including, without limitation,
those listed in the “Risk Factors” section of the Company’s Annual
Information Form dated March 29, 2019 (which may be viewed at
www.sedar.com). Should one or more of these risks or uncertainties
materialize, or should assumptions underlying the forward-looking
statements prove incorrect, actual results, performance, or
achievements may vary materially from those expressed or implied by
the forward-looking statements contained in this news release.
These factors should be considered carefully, and prospective
investors should not place undue reliance on the forward-looking
statements. Although the forward-looking statements contained in
the news release are based upon what management currently believes
to be reasonable assumptions, the Company cannot assure prospective
investors that actual results, performance or achievements will be
consistent with these forward-looking statements.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190613005364/en/
LHA Investor RelationsKim Sutton Golodetz(212)
838-3777kgolodetz@lhai.comorBruce Voss(310)
691-7100bvoss@lhai.com
Titan Medical (NASDAQ:TMDI)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Titan Medical (NASDAQ:TMDI)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024